Montelukast to improve kidney and blood vessel function in type 1 diabetes
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether montelukast, a medicine commonly used for allergies, can improve kidney health and blood vessel function in adults with long-term type 1 diabetes. You may join a treatment group and have kidney and circulation measurements taken over the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80
- You have type 1 diabetes for at least 5 years
- Your urine test shows albumin/creatinine ratio between 30 and 5000
- Your kidney filtration (eGFR) is between 30 and 89
- Your blood pressure is under 140/90 and stays on a stable plan
- You use stable insulin treatment (automated pump or multiple daily injections) for at least 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called an SGLT2 inhibitor (canagliflozin-like) can help slow kidney disease in people with type 1 diabetes. It may help protect your kidneys if you already have protein in your urine and reduced kidney function.
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
This study tests a once-daily pill called finerenone to see if it can reduce protein in the urine (a sign of kidney damage) in people with type 2 diabetes and chronic kidney disease. It may help protect your kidneys and slow down disease progression.
This trial tests if montelukast, a common asthma medicine, can help protect the kidneys, heart, and eyes in people with type 2 diabetes. It is for those who already have some kidney damage (stage 2-3) and are taking certain blood pressure or diabetes medications.
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
This study tests new treatments to protect the heart and kidneys in people with long-standing type 1 diabetes. It aims to prevent or slow down complications like heart failure and kidney damage.
Hear when a new Albuminuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.